Literature DB >> 10532252

Tolerability profile of SERMs.

D Agnusdei1, N Iori.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10532252     DOI: 10.1007/BF03343622

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  25 in total

Review 1.  Selective estrogen receptor modulators: an alternative to hormone replacement therapy.

Authors:  H U Bryant; W H Dere
Journal:  Proc Soc Exp Biol Med       Date:  1998-01

2.  A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women.

Authors:  M W Draper; D E Flowers; W J Huster; J A Neild; K D Harper; C Arnaud
Journal:  J Bone Miner Res       Date:  1996-06       Impact factor: 6.741

3.  Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women.

Authors:  T Nickelsen; E G Lufkin; B L Riggs; D A Cox; T H Crook
Journal:  Psychoneuroendocrinology       Date:  1999-01       Impact factor: 4.905

4.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

5.  Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

Authors:  J P Vandenbroucke; T Koster; E Briët; P H Reitsma; R M Bertina; F R Rosendaal
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

6.  Risk of venous thromboembolism in users of hormone replacement therapy.

Authors:  E Daly; M P Vessey; M M Hawkins; J L Carson; P Gough; S Marsh
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

7.  The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly.

Authors:  W D Kniffin; J A Baron; J Barrett; J D Birkmeyer; F A Anderson
Journal:  Arch Intern Med       Date:  1994-04-25

8.  Amygdala neurons in vitro: neurite growth and effects of estradiol.

Authors:  A Lorenzo; H Díaz; H Carrer; A Cáceres
Journal:  J Neurosci Res       Date:  1992-11       Impact factor: 4.164

9.  Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.

Authors:  U Veronesi; P Maisonneuve; A Costa; V Sacchini; C Maltoni; C Robertson; N Rotmensz; P Boyle
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

Review 10.  Can estrogens prevent neurodegeneration?

Authors:  L S Schneider; C E Finch
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 4.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.